I am the co-founder and CEO at Pine Biotech - a company that merges big -omics data analysis with clinical care and precision applications for Real World Evidence: research & development of new targets and therapeutics, stratified clinical trials, and development of biomarkers for early detection and companion diagnostics. We want to improve patient outcomes and provide tools for researchers and clinicians to have an impact on healthcare. The current startup won international awards and we were able to raise over $1 million USD. Previously started 2 other startups in multimedia and marketing.
CEO, Pine Biotech, INC - Bioinformatics, Big Data Analysis, Data Science
Mar 2014 to Present
The diseases we identify observing visible or measurable phenotypes are complex disorders with huge variation between individuals. The standard approach utilizes a heavy chemical bombardment of many intricate cellular mechanisms. The result is mediocre improvement with serious side effects, low efficiency and even serious health risk. Sometimes, this is a result of our lack of understanding because we don't have the time to understand or measure what we are trying to "fix". This is often the reason why healthcare is so inefficient and expensive. Collectively, we have been investing time and money into understanding how the molecular machinery functions inside every cell. Researchers now know that the complex network of relationships between genetic code, proteins and intra-cellular communication has the key to solving some of the most pressing challenges in healthcare - from cancer to chronic diseases, to infectious diseases. This data can be captured on an individual level and analyzed for previously undetectable irregularities. With more and more data generated, this is a challenge of data mining. Our company focus is on analysis of molecular data, or "omics" data because it contains information on an unprecedented level of precision. By enabling researchers and clinicians to extract real insight from 'omics data, we hope that new and more effective approaches to diagnostics and therapeutics will be developed. Eventually, the efficiency of early detection and new targeted therapeutics will translate into longer, healthier lives for patients, with less side effects and cheaper treatments or completely new ways to manage disease. Industries: Biotechnology, Bioinformatics, Computational Biology, Big Data Analysis, Data Science, Antiviral and Vaccine Development, Simulation, Biostatistics, Systems Biology Technologies: Data Science, Biostatistics, Mathematical Modeling, Big Data